BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32959695)

  • 1. MiR-32-5p knockdown inhibits epithelial to mesenchymal transition and renal fibrosis by targeting SMAD7 in diabetic nephropathy.
    Wang HJ; Liu H; Lin YH; Zhang SJ
    Hum Exp Toxicol; 2021 Apr; 40(4):587-595. PubMed ID: 32959695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
    Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
    Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
    Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
    Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B
    Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-17 suppresses TGF-β1-mediated renal fibrosis through targeting Smad7.
    Fu H; Chu D; Geng X
    Mol Cell Biochem; 2021 Aug; 476(8):3051-3064. PubMed ID: 33797702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.
    McClelland AD; Herman-Edelstein M; Komers R; Jha JC; Winbanks CE; Hagiwara S; Gregorevic P; Kantharidis P; Cooper ME
    Clin Sci (Lond); 2015 Dec; 129(12):1237-49. PubMed ID: 26415649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_WBSCR17 aggravates inflammatory responses and fibrosis by targeting miR-185-5p/SOX6 regulatory axis in high glucose-induced human kidney tubular cells.
    Li G; Qin Y; Qin S; Zhou X; Zhao W; Zhang D
    Life Sci; 2020 Oct; 259():118269. PubMed ID: 32798559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-30c-5p inhibits high glucose-induced EMT and renal fibrogenesis by down-regulation of JAK1 in diabetic nephropathy.
    Gao BH; Wu H; Wang X; Ji LL; Chen C
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1338-1349. PubMed ID: 32096183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA MALAT1 facilities high glucose induced endothelial to mesenchymal transition and fibrosis via targeting miR-145/ZEB2 axis.
    Liu B; Qiang L; Wang GD; Duan Q; Liu J
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3478-3486. PubMed ID: 31081103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy.
    Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J
    Eur J Pharmacol; 2018 Oct; 837():96-104. PubMed ID: 30125566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy.
    Meng Q; Zhai X; Yuan Y; Ji Q; Zhang P
    Braz J Med Biol Res; 2020; 53(4):e9288. PubMed ID: 32294702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High glucose down-regulates microRNA-181a-5p to increase pro-fibrotic gene expression by targeting early growth response factor 1 in HK-2 cells.
    Xu P; Guan MP; Bi JG; Wang D; Zheng ZJ; Xue YM
    Cell Signal; 2017 Feb; 31():96-104. PubMed ID: 28077323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A.
    Yang J; Shen Y; Yang X; Long Y; Chen S; Lin X; Dong R; Yuan J
    Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1350-F1358. PubMed ID: 31545928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icariin inhibits epithelial mesenchymal transition of renal tubular epithelial cells via regulating the miR-122-5p/FOXP2 axis in diabetic nephropathy rats.
    Zang L; Gao F; Huang A; Zhang Y; Luo Y; Chen L; Mao N
    J Pharmacol Sci; 2022 Feb; 148(2):204-213. PubMed ID: 35063135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Dodecyl-6-Methoxycyclohexa-2, 5-Diene-1, 4-Dione isolated from Averrhoa carambola L. root inhibits high glucose-induced EMT in HK-2 cells through targeting the regulation of miR-21-5p/Smad7 signaling pathway.
    Li J; Pang Q; Huang X; Jiang H; Tang G; Yan H; Guo Y; Yan X; Li L; Zhang H
    Biomed Pharmacother; 2024 Mar; 172():116280. PubMed ID: 38368837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminution of microRNA-98 alleviates renal fibrosis in diabetic nephropathy by elevating Nedd4L and inactivating TGF-β/Smad2/3 pathway.
    Zeng Y; Feng Z; Liao Y; Yang M; Bai Y; He Z
    Cell Cycle; 2020 Dec; 19(24):3406-3418. PubMed ID: 33315506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy.
    Du L; Qian X; Li Y; Li XZ; He LL; Xu L; Liu YQ; Li CC; Ma P; Shu FL; Lu Q; Yin XX
    Acta Pharmacol Sin; 2021 Feb; 42(2):242-251. PubMed ID: 32555442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-455-3p suppresses renal fibrosis through repression of ROCK2 expression in diabetic nephropathy.
    Wu J; Liu J; Ding Y; Zhu M; Lu K; Zhou J; Xie X; Xu Y; Shen X; Chen Y; Shao X; Zhu C
    Biochem Biophys Res Commun; 2018 Sep; 503(2):977-983. PubMed ID: 29932921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA OIP5-AS1 induces epithelial-to-mesenchymal transition and renal fibrosis in diabetic nephropathy via binding to miR-30c-5p.
    Fu JX; Sun GQ; Wang HL; Jiang HX
    J Biol Regul Homeost Agents; 2020; 34(3):961-968. PubMed ID: 32519534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ski-related novel protein suppresses the development of diabetic nephropathy by modulating transforming growth factor-β signaling and microRNA-21 expression.
    Wang Y; Liu L; Peng W; Liu H; Liang L; Zhang X; Mao Y; Zhou X; Shi M; Xiao Y; Zhang F; Zhang Y; Liu L; Yan R; Guo B
    J Cell Physiol; 2019 Aug; 234(10):17925-17936. PubMed ID: 30847937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.